Catalent’s Senior Vice President & Chief Financial Officer, Wetteny Joseph, Inducted as a Member of the Executive Leadership Council
The ELC is a global organization comprised of more than 800 current and former black CEOs, board members, and senior executives of Fortune 1000 and Global 500 companies, entrepreneurs at top-tier firms, and thought leaders. The ELC opens channels of opportunity for the development of black executives to positively impact business and communities.
Speaking at a pinning ceremony on Feb. 20, Mr. Joseph commented, “I am deeply honored to become a member of the ELC. The organization has a rich history in opening channels of opportunity and having a significant impact in the development of black executives.” He added, “Since its inception in 1986, the ELC has demonstrated its capacity for improving the black business community, and the black community overall, through its range of both business and philanthropic activities.”
Mr. Joseph first joined Catalent in 2008 as Vice President and Corporate Controller and held various senior finance roles until October 2015, when he was named President, Clinical Supply Services. Subsequently, in February 2018, he was appointed Senior Vice President and Chief Financial Officer.
Before joining Catalent, Mr. Joseph held a variety of senior financial positions at the industrial distribution company HD Supply including CFO for its $1.2 billion plumbing and HVAC business unit. He also served as Corporate Controller at Hughes Supply, a Fortune 500, NYSE-listed company that was acquired by Home Depot and became part of HD Supply. In his early career, Mr. Joseph spent six years at PricewaterhouseCoopers as an auditor and strategic financial advisor across a variety of industries.
Mr. Joseph earned both his master’s and bachelor’s degrees in accounting from Florida Atlantic University and is a Certified Public Accountant.
Catalent is the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. With over 85 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable global clinical and commercial product supply. Catalent employs over 13,000 people, including over 2,400 scientists and technicians, at more than 35 facilities, and in fiscal year 2019 generated over $2.5 billion in annual revenue. Catalent is headquartered in Somerset, New Jersey. For more information, visit www.catalent.com